These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 17129727)

  • 1. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
    Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
    Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy.
    Sinnreich M; Therrien C; Karpati G
    Neurology; 2006 Apr; 66(7):1114-6. PubMed ID: 16606933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
    Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
    Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
    Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
    Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
    Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
    Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel DYSF mutations in Thai patients with distal myopathy.
    Liewluck T; Pongpakdee S; Witoonpanich R; Sangruchi T; Pho-Iam T; Limwongse C; Thongnoppakhun W; Boonyapisit K; Sopassathit V; Phudhichareonrat S; Suthiponpaisan U; Raksadawan N; Goto K; Hayashi YK; Nishino I
    Clin Neurol Neurosurg; 2009 Sep; 111(7):613-8. PubMed ID: 19493611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population.
    Vilchez JJ; Gallano P; Gallardo E; Lasa A; Rojas-García R; Freixas A; De Luna N; Calafell F; Sevilla T; Mayordomo F; Baiget M; Illa I
    Arch Neurol; 2005 Aug; 62(8):1256-9. PubMed ID: 16087766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
    Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
    J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
    Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
    Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected].
    Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA
    Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limb-girdle muscular dystrophy due to emerin gene mutations.
    Ura S; Hayashi YK; Goto K; Astejada MN; Murakami T; Nagato M; Ohta S; Daimon Y; Takekawa H; Hirata K; Nonaka I; Noguchi S; Nishino I
    Arch Neurol; 2007 Jul; 64(7):1038-41. PubMed ID: 17620497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
    Piccolo F; Moore SA; Ford GC; Campbell KP
    Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
    Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
    Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
    Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.
    Cagliani R; Magri F; Toscano A; Merlini L; Fortunato F; Lamperti C; Rodolico C; Prelle A; Sironi M; Aguennouz M; Ciscato P; Uncini A; Moggio M; Bresolin N; Comi GP
    Hum Mutat; 2005 Sep; 26(3):283. PubMed ID: 16100712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Private dysferlin exon skipping mutation (c.5492G>A) with a founder effect reveals further alternative splicing involving exons 49-51.
    Santos R; Oliveira J; Vieira E; Coelho T; Carneiro AL; Evangelista T; Dias C; Fortuna A; Geraldo A; Negrão L; Guimarães A; Bronze-da-Rocha E
    J Hum Genet; 2010 Aug; 55(8):546-9. PubMed ID: 20535123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect.
    Jaiswal JK; Marlow G; Summerill G; Mahjneh I; Mueller S; Hill M; Miyake K; Haase H; Anderson LV; Richard I; Kiuru-Enari S; McNeil PL; Simon SM; Bashir R
    Traffic; 2007 Jan; 8(1):77-88. PubMed ID: 17132147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel mitochondrial DNA mutations in muscle tissue of a patient with limb-girdle myopathy.
    Meulemans A; De Paepe B; De Bleecker J; Smet J; Lissens W; Van Coster R; De Meirleir L; Seneca S
    Arch Neurol; 2007 Sep; 64(9):1339-43. PubMed ID: 17846276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.
    Lo HP; Cooper ST; Evesson FJ; Seto JT; Chiotis M; Tay V; Compton AG; Cairns AG; Corbett A; MacArthur DG; Yang N; Reardon K; North KN
    Neuromuscul Disord; 2008 Jan; 18(1):34-44. PubMed ID: 17897828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the DYSF mutational spectrum in a large cohort of patients.
    Krahn M; Béroud C; Labelle V; Nguyen K; Bernard R; Bassez G; Figarella-Branger D; Fernandez C; Bouvenot J; Richard I; Ollagnon-Roman E; Bevilacqua JA; Salvo E; Attarian S; Chapon F; Pellissier JF; Pouget J; Hammouda el H; Laforêt P; Urtizberea JA; Eymard B; Leturcq F; Lévy N
    Hum Mutat; 2009 Feb; 30(2):E345-75. PubMed ID: 18853459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.